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Abstract
Plasminogen activator inhibitor (PAI-1) is induced in the vasculature and
secreted into the vascular lumen in response to inflammation and oxidative
stress. We have previously reported a fivefold increase in plasma PAI-1 from
rats exposed to 708 kPa hyperbaric air. In the current study we assess the
potential of human serum total PAI-1 as a biomarker for stress in compressed
air diving. Eleven recreational divers, nine males and two females, completed
four 2 h hyperbaric air exposures to 280 kPa in a pressure chamber over a
period of 2 weeks. The air pressure corresponds to a diving depth of 18 m in
water. Serum was collected before the study and again 3 h 30 min after com-
pletion of each hyperbaric exposure. All samples were taken in the afternoon
to minimize the contribution of circadian variation. The analysis revealed no
change in serum total PAI-1 after hyperbaric exposures within the group of
divers (P = 0.064), but significant interindividual differences persisted
throughout the study (P < 0.0005). A case of decompression sickness after the
third round of hyperbaric exposure did not affect PAI-1. In conclusion, com-
pressed air exposure to 280 kPa does not affect serum total PAI-1, and signifi-
cant interindividual variation in PAI-1 levels may limit its usefulness as a
biomarker. This does, however, not give a complete answer regarding PAI-1
in physiologically stressful dives. Further studies with different exposures and
timing are needed for that.
Introduction
In compressed air diving, the diver breathes air at a den-
sity equal to that of the surrounding medium. Elevated
oxygen pressure during submersion and nitrogen gas
released as bubbles during decompression stress the circu-
latory system and may provoke a variety of symptoms
collectively known as decompression sickness (DCS)
(Vann et al. 2011). The self-reported incidence of DCS is
low (0.155%) (Ranapurwala et al. 2014), but even asymp-
tomatic air dives are associated with proinflammatory
responses, augmented oxidative stress (Eftedal et al. 2013;
Sureda et al. 2014) and transient endothelial dysfunction
(Brubakk et al. 2005). The rareness of DCS speaks of a
vital balance between the disruptive propensity of hyper-
baric environments and the individual diver’s capacity for
biological compensation, and factors that drive this bal-
ance may be suitable biomarkers for the assessment of
physiological stress in diving.
We have previously reported that exposure to 708 kPa
compressed air, corresponding to a water depth of 60 m,
activates target genes for redox-sensitive transcription
factors in the rat aorta (Eftedal et al. 2012). Interestingly,
these gene expression changes occurred independently
of decompression-induced bubbles, as there were no dif-
ferences between the responses of animals without
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detectable vascular bubbles compared to those with high
bubble loads in their venous circulation after decompres-
sion. Among the upregulated genes was Serpine1, which
codes for the serine protease inhibitor PAI-1. The Ser-
pine1 activation was followed by a fivefold increase in
PAI-1 protein in blood. PAI-1 is a central regulator of
fibrinolysis; in unstressed cells PAI-1 preserves the basal
fibrinolytic activity by inhibiting plasminogen activation
by tissue-type and urokinase-type plasminogen activator
(t-PA and u-PA) (Eitzman et al. 2000). PAI-1 activity is
tightly regulated at the transcriptional level, and there is
constitutive PAI-1 expression in a variety of cell types,
including endothelial cells, smooth muscle cells, macro-
phages, hepatocytes, adipocytes, and platelets (Booth
et al. 1988; Brogren et al. 2004; Dellas and Loskutoff
2005).
Oxidative stress enhances Serpine1 gene expression
beyond basal levels in vascular cells (Vulin and Stanley
2004; Liao et al. 2007), and triggers the release of PAI-1
into the vascular lumen (Kawasaki et al. 2000). In addi-
tion to its direct prothrombotic function, PAI-1 also
stimulates the formation of procoagulant microparticles
(Brodsky et al. 2002). It is plausible that high PAI-1 in
response to oxidative stress is beneficial from an evolu-
tionary viewpoint: proinflammatory cytokines activate
their responses via oxidative stress signaling, and an eleva-
tion of PAI-1 may promote coagulation as a protective
response, possibly limiting the spread of infections or
excessive bleeding in traumatic injury (Esmon et al.
2011). There is, however, a flip side. Elevated PAI-1 over
time promotes atherosclerosis (Binder et al. 2002), and is
associated with the risk of several diseases, among them
thrombotic vascular diseases (Eitzman et al. 2000; Kohler
and Grant 2000), and aseptic bone necrosis (Jones et al.
2003).
In this study we examine PAI-1 as a potential biomar-
ker for physiological stress in exposure to hyperbaric air.
Based on our previous observations in rats, we hypothe-
sized that total PAI-1 in human serum would be elevated
after dry pressure chamber dives. The study protocol was
chosen to reflect total and oxygen pressures, exposure
times, and decompression stress that may be encountered
in recreational diving, so that the results would be rele-
vant to divers at large.
Materials and Methods
Research ethics
The study was approved in advance by the Norwegian
Regional Committee for Medical and Health Research
Ethics (REK approval no 2013/2251), and conducted in
compliance with the Declaration of Helsinki ethical prin-
ciples for human experimentation. Participation was
based on written informed consent. The participants were
provided with Divers Alert Network (DAN) Europe divers
insurance for 1 year from the start of the study. A diving
physician was on-call in the vicinity of the study site
during the hyperbaric exposures and postexposure obser-
vations, and the pressure chamber was set up for hyper-
baric oxygen treatment (US Navy table 6) in case any
participant developed symptoms of DCS.
Study participants
Eleven currently active recreational divers, two females
and nine males, aged 20 to 47 years (34  6 years,
mean  SD) were included in the study after passing a
medical examination based on the criteria for health
clearance of inshore occupational divers from the Norwe-
gian Board of Health (Norwegian guidelines for medical
examination of occupational divers 2000). In addition to
recording of sex, age, weight, and height, the examination
included measurements of pulmonary function (spirome-
try, data not shown), maximal oxygen uptake (VO2max
treadmill test), and serum total cholesterol, low-density
lipoprotein cholesterol (LDL-C) and high-density lipopro-
tein cholesterol (HDL-C). During the examination one
diver reported a previous incidence of possible DCS for
which he had received hyperbaric oxygen treatment with-
out consulting a physician 1 year earlier; no other cases
of prior diving-related injury were reported among the
participants. After inclusion, participation in any specific
hyperbaric exposure during the study was contingent the
diver not having obstructive symptoms of the upper
respiratory tract as this might cause difficulty with middle
ear pressure equilibration.
Hyperbaric exposure
The hyperbaric exposures were performed in a 13,000 L
pressure chamber (Dr€ager, Dr€agerwerk L€ubeck,
Germany), localized at Høvringen outside Trondheim and
managed by pressure chamber operators from the local
fire and rescue service. The participating divers were ran-
domly assigned to four groups, each consisting of 2 or 3
persons. Two groups were scheduled for hyperbaric expo-
sure on each study day; one group before lunch (9.30 to
11.30 AM) and one group after lunch (12 to 2 PM). For
each participant, singular exposures were set 72 or 96 h
apart in order to abolish any transient responses between
exposures (Obad et al. 2007). The dive profiles followed
the Norwegian diving and treatment tables version 3
(Arntzen et al. 2004) with a bottom pressure of 280 kPa,
corresponding to 18 m of sea-water. Compression to
280 kPa was done at 150 kPamin1. After the divers
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were kept at a bottom pressure of 280 kPa for 100 min,
decompression was performed at a rate of 90 kPamin1
with two decompression stops: the first at 160 kPa for
5 min, and the second at 130 kPa for 15 min. While in
the chamber, the divers had visual and audial contact
with the chamber operators at all times.
Blood sampling and serum protein analyses
In order to limit the effects of circadian variation on bio-
marker levels, the timing was set so that all blood samples
would be drawn in the afternoon between 3 and 5.30 PM,
when PAI-1 would be at a relatively stable minimal daily
level (Scheer and Shea 2014). Blood for analyses was
collected on 5 mL Serum Sep Clot Activator + Gel tubes
(Vacuette, Greiner Bio-One International GmbH, Krems-
muenster, Austria) by standard venipuncture at the pre
dive-medical examination, and again 3 h 30 min after
completion of each hyperbaric exposure. After inversion,
the blood tubes were left to clot for 30 min at room tem-
perature before centrifugation at 10,000 g for 10 min.
Serum was stored at 80°C until analyzed. Four individual
samples were missing, either because the diver was not pre-
sent for testing (preexposure diver 7, and post2 diver 3), or
exclusion from individual dives due to symptoms of com-
mon cold (post1 diver 9), and decompression sickness
(post4 diver 3).
Total PAI-1, comprising the active and latent forms of
PAI-1 in serum, was measured with the human total Ser-
pin E1/PAI-1 Quantikine ELISA Kit from R&D Systems
(catalog no DTSE100, Minneapolis, MN). The producer
had validated the reagents for serum values of 35.8–
137 ng mL1, and by titration we determined a 25-fold
dilution of serum samples used in the final analysis. The
samples were run in duplicates according to the manufac-
turer’s protocol. OD values were measured at 450 mn
using microplate reader (Asys Expert Plus, Biochrom
Ltd., Cambridge, UK), and the total PAI-1 concentration
was calculated from the standard curves using sample
mean OD values with blank correction.
Serum cortisol was measured to assess general stress
levels that might affect cardiovascular function (Lazzarino
et al. 2013). The analysis was done using the Cobas
human cortisol ECLIA kit (catalog no 11875116160) on a
Modular E 170 immunochemistry analyzer, both from
Roche Diagnostic (Hoffmann-La Roche Ltd, Basel, Swit-
zerland).
Statistical analysis
A prospective sample size power calculation for PAI-1
analysis was done using IBM SPSS Sample Power (Ver-
sion 3, IBM Corp., Armonk, NY). Eleven participants
provided an estimated power of 80% with an a error
probability of 0.05 based on plasma PAI-1 data from a
general adult population (Margaglione et al. 1998).
All statistical data analyses were performed using IBM
SPSS Statistics software (Version 21.0. IBM Corp.).
Kolmogorov–Smirnov test and Q–Q normal probability
plots verified that the biomarker measurements were nor-
mally distributed; thus parametric tests were used in fur-
ther analyses. A linear mixed model was employed to
assess the effect of repeated hyperbaric exposures on the
level of total PAI-1 and cortisol, with time of sampling
as a fixed categorical factor and diver id as a random fac-
tor. One-way analysis of variance (ANOVA) was used to
identify statistical differences in serum biomarker levels
between the divers. The level of significance was set at
P ≤ 0.05.
Results
Individual diver characteristics
Individual anthropometric, blood cholesterol, and fitness
data for the participating divers are shown in Table 1.
According to BMI derived from the participants’ weight
and height, six divers were of normal weight, one was
underweight, and four were overweight. None were obese.
The serum cholesterol values: total cholesterol, HDL-C,
and LDL-C, were all within normal range relative to the
participants’ sex and age. All participants had VO2max val-
ues within the age-dependent requirements for occupa-
tional diving from the Norwegian Board of Health
(Norwegian guidelines for medical examination of occupa-
tional divers 2000).
Serum total PAI-1 and cortisol
Serum total PAI-1 and cortisol measured before the study,
and again 3 h 30 min after each of the four hyperbaric
exposures, are presented in Figures 1 and 2. Figures 1A
and 2A shows that single or repeated hyperbaric exposures
did not affect serum levels of total PAI-1 (P = 0.064) or
cortisol (P = 0.286). However, as shown in Figure 1B, PAI-
1 varied significantly between individual divers (P < 0.0005).
Cortisol levels were not different between the divers, Fig-
ure 2B (P = 0.122). Diver number 3 developed symptoms
of DCS approximately 24 h after the third hyperbaric
exposure; this had no effect on serum total PAI-1 or
cortisol levels 3 h 30 min after this exposure. The
participant, not the same diver who reported having
experienced DCS 1 year earlier, was excluded from the
rest of the study with no further measurements done. He
was diagnosed with neurological DCS and received treat-
ment and follow-up according to medical procedures.
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Table 1. Individual diver anthropometrics, cholesterol and fitness data.
Diver id Sex
Anthropometrics
Serum cholesterol
[mmolL1]1 Aerobic fitness
Age (years) Weight (kg) Height (cm) Total HDL LDL VO2max
2 Peak HR3
1 M 20 55.5 185 3.8 1.2 2.3 56.2 213
2 M 36 79.5 180 5.3 1.1 3.5 49.6 188
3 M 39 76.0 172 4.0 0.9 2.4 49.1 182
4 F 47 60.9 157 4.6 2.2 1.0 34.0 183
5 M 27 74.9 186 4.6 1.4 2.5 61.2 235
6 F 42 88.0 174 4.8 1.7 2.7 37.7 184
7 M 32 95.5 189 5.9 1.3 3.8 53.2 185
8 M 32 83.1 185 4.1 1.2 2.0 51.1 198
9 M 44 93.5 183 6.1 1.3 3.9 46.5 196
10 M 30 69.4 175 4.8 1.3 2.9 62.3 188
11 M 22 65.3 180 4.4 2.1 1.9 57.4 194
Mean 34 76.5 179 4.8 1.4 2.6 50.8 195
SD 9 13.0 9 0.7 0.4 0.9 8.9 16
1All cholesterol values are within normal range for the participants’ sex and age.
2Maximum rate of oxygen consumption measured during treadmill exercise, mLmin1 kg1.
3Heart rate, min1 at VO2max.
A B
Figure 1. Serum total PAI-1. (A) Serum total PAI-1 according to the time of measurement. Only divers for whom all five samples were
available are included (n = 8). There are no differences in serum total PAI-1 before and after hyperbaric exposures within the group. (B) All
serum total PAI-1 values measured are sorted according to individual diver id (n = 11). There is significant interindividual variation in serum total
PAI-1 between divers (P < 0.0005). A triangle (▲) marks data from diver 3 for the hyperbaric exposure preceding DCS symptoms. In both
panels, red symbols are used for predive values, black for postdive values. Horizontal lines indicate means.
A B
Figure 2. Serum cortisol. (A) Values are sorted according to the time of measurements. Only divers for whom all five samples were available
are included (n = 8). (B) All serum cortisol measured sorted by individual diver id (n = 11). There are no differences in serum cortisol within the
group, or between individual divers. In both panels, red symbols are used for predive values, black for postdive values. Horizontal lines indicate
means.
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Discussion
No changes in serum total PAI-1 were observed in
response to a series of hyperbaric air exposures to
280 kPa in this study. A case of DCS after the third
round of hyperbaric exposures indicates that the stress was
significant, but the affected diver had unaltered PAI-1 lev-
els also in the measurement that preceded his symptoms.
The incentive for examining PAI-1 as a stress biomar-
ker in diving came from rat studies where hyperbaric air
triggered a large increase in plasma PAI-1 independently
of whether vascular bubbles were present after decom-
pression (Eftedal et al. 2012). Rodents are convenient
models for exposures that lie beyond the limits for safe
human diving, and the rat exposures were more provoca-
tive than those reported here with regards to partial pres-
sure of oxygen (ppO2) and decompression stress: the
ppO2 at maximum pressure was 149 kPa in the rat study
versus 59 kPa in the present study. A linear decompres-
sion 50 kPamin1 was used for the rats; versus staged
decompression following an established diving protocol in
the present study. These differences may explain the
divergent results. Also, the rats were all of equal genetic
and environmental background. The divers in the present
study were approved for participation on basis of medical
criteria for occupational diving, but as shown in Table 1
their individual traits varied considerably. Even if PAI-1
levels positively correlates with long-term risk for a num-
ber of cardiovascular diseases, its usefulness as a biomar-
ker for transient physiological stress in healthy subjects
may be limited by the normal variability in human PAI-1.
Basal PAI-1 levels depends significantly on, for example,
sex, age, obesity, cholesterol levels, and physical fitness
(Margaglione et al. 1998; Alessi and Juhan-Vague 2006;
Cesari et al. 2010; Lira et al. 2010), which may explain
the observed interindividual differences in serum total
PAI-1. Common genetic variants of the Serpine1 gene are
also thought to affect PAI-1 protein levels (Margaglione
et al. 1998); these are, however, outside the scope of this
study.
In addition to its potential value as a stress biomarker,
PAI-1 has a direct role in the pathophysiology of diving.
Aseptic bone necrosis is an established complication in
frequent and deep diving (Aseptic Bone Necrosis in
Commercial Divers 1981; Cimsit et al. 2007), and high
PAI-1 has been found to be an independent predictor of
bone necrosis in male occupational divers (Miyanishi
et al. 2006). If PAI-1 is elevated by diving in itself, as
indicated by our earlier rat study, this may be detrimen-
tal to the diver’s skeletal health in a long-term perspec-
tive. Both our previous report on rats and the current
study on human divers are, however, conflicting with a
previous study in which PAI-1 in human plasma was
decreased after 30 min compressed air exposures to 400
and 700 kPa (Radziwon et al. 2007). However, when
comparing the Radziwon study and the current, in addi-
tion to the differences in material for analysis, for exam-
ple, serum versus plasma, there are protocol differences
that may explain the discrepancy. Beside the differences
in hyperbaric exposure, the timing of the PAI-1 mea-
surements was dissimilar. In the current study, the tim-
ing of blood sampling was decided on the basis of two
factors. First, there is a pronounced circadian variation
in PAI-1 levels in human blood (Angleton et al. 1989;
Scheer and Shea 2014), with values peaking in the early
morning, falling toward mid-day, and remaining rela-
tively stable in the afternoon and evening. We therefore
did all blood sampling in the afternoon, whereas the pre-
exposure samples for the Radziwon study appear to have
been drawn on the day of exposure. Second, the time it
takes from upregulation of the Serpine1 gene in vascular
cells to detectable secretion of PAI-1 into the vascular
lumen is a factor to consider. In vitro studies indicate
that several hours are needed before upregulated gene
transcription results in a detectable rise in secreted extra-
cellular PAI-1 (Handt et al. 1996; Jeong et al. 2011). In
the current study, 5 h 30 min separated the start of the
hyperbaric exposures and the postexposure blood sam-
pling, which probably puts us in the early phases of a
potential rise in PAI-1. Even later measurement might
have revealed an increase, but for practical reasons this
was not done.
Limitations
Most of the circulating PAI-1 in healthy individuals is
contained within platelets (Booth et al. 1988). The aim of
this study was to identify stress-induced changes in PAI-1
presumably secreted from the vasculature; serum was cho-
sen to avoid contributions from platelets that might mask
smaller changes. There is a risk of platelet lysis with
release of PAI-1 during serum preparation. However, the
stability of the intraindividual measurements and consis-
tent interindividual differences in total PAI-1 throughout
the study leads us to believe that the serum results reflect
genuine biology.
The hyperbaric exposures in this study were done in a
pressure chamber, and there are some notable differences
in the cardiovascular responses to breathing hyperbaric
air in a dry environment and diving in water. Among
them is the altered distribution of blood from the extrem-
ities to the chest cavity during water immersion, and con-
striction of peripheral blood vessels in response to cold
water. The resulting increases of the heart’s work-load
and blood pressure contribute to the physiological stress
in diving, and are not addressed in this study.
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Conclusion
There is no effect of exposure to 280 kPa hyperbaric air
on total PAI-1 levels in human serum. Significant interin-
dividual variation in basal PAI-1 levels is likely to limit
its usefulness as a biomarker for physiological stress in
recreational diving. This does, however, not provide a
complete answer regarding the usefulness of PAI-1 mea-
surements in diving. Further studies with different expo-
sures and timing are needed for that.
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In this study we have examined whether human serum total PAI-1 levels change in response to 2 h hyperbaric exposure
to dry air at 280 kPa. Despite indications of physiological stress after the exposure we observed no change in PAI-1, and
conclude that a significant interindividual variation may limit the usefulness of PAI-1 as a biomarker for physiological stress
in diving.
